Scarica l'app Stockscreener
74.36
7.02%
4.88
Dopo l'orario di chiusura:
74.37
0.01
+0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$69.48
Aprire:
$69.62
Volume 24 ore:
768.39K
Relative Volume:
1.15
Capitalizzazione di mercato:
$2.04B
Reddito:
$267.23M
Utile/perdita netta:
$-83.50M
Rapporto P/E:
-23.91
EPS:
-3.11
Flusso di cassa netto:
$-59.99M
1 W Prestazione:
+3.27%
1M Prestazione:
-3.93%
6M Prestazione:
+133.62%
1 anno Prestazione:
+2,195%
Intervallo 1D:
$69.62
$75.22
Intervallo di 1 settimana:
$66.81
$77.00
Portata 52W:
$2.85
$98.87
Genedx Holdings Corp Stock (WGS) Company Profile
Nome
Genedx Holdings Corp
Settore
Industria
Telefono
617 780 8742
Indirizzo
333 LUDLOW STREET, STAMFORD
Confronta WGS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
74.36 | 2.04B | 267.23M | -83.50M | -59.99M | -3.11 |
|
VEEV
Veeva Systems Inc
|
223.04 | 36.21B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.02 | 12.79B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
55.52 | 10.37B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
104.74 | 9.08B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
47.64 | 7.50B | 640.44M | -743.28M | -206.93M | -11.29 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-07-10 | Iniziato | Craig Hallum | Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
Genedx Holdings Corp Borsa (WGS) Ultime notizie
Institutional owners may ignore GeneDx Holdings Corp.'s (NASDAQ:WGS) recent US$427m market cap decline as longer-term profits stay in the green - Yahoo Finance
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 17, 2025 - BioSpace
(WGS) Technical Data - Stock Traders Daily
Assenagon Asset Management S.A. Sells 61,642 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx (NASDAQ:WGS) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
GeneDx (NASDAQ:WGS) Trading Down 7.2%Here's What Happened - MarketBeat
Barclays PLC Acquires 14,681 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
GeneDx Holdings: A Phenomenal Comeback With More Room To Run - Seeking Alpha
GeneDx raises Q4 adjusted gross margin view to 68% from 64% - Yahoo Finance
GeneDx Holdings (WGS) Surges 13.2%: Is This an Indication of Further Gains? - MSN
GeneDx anticipates higher-than-expected annual revenues - MSN
GeneDx Holdings Expects Strong 2024 Financial Performance - TipRanks
GeneDx forecasts strong revenue and gross margin growth By Investing.com - Investing.com South Africa
Why Have GeneDx Holdings Stocks Plummeted? - TipRanks
GeneDx forecasts strong revenue and gross margin growth - Investing.com India
GeneDx Announces Preliminary 2024 Financial Results - Business Wire
Insider Sell: Katherine Stueland Sells 51,420 Shares of GeneDx H - GuruFocus.com
Genedx CEO sells shares worth $4.86 million - Investing.com India
Genedx CEO sells shares worth $4.86 million By Investing.com - Investing.com Australia
GeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells $3,331,172.92 in Stock - MarketBeat
GeneDx Holdings Corp. (NASDAQ:WGS) CEO Katherine Stueland Sells 51,420 Shares - MarketBeat
GeneDx (NASDAQ:WGS) Stock Price Down 6.3%What's Next? - MarketBeat
GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers - Business Wire
How the (WGS) price action is used to our Advantage - Stock Traders Daily
TD Cowen Boosts GeneDx (NASDAQ:WGS) Price Target to $118.00 - Defense World
GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients - Business Wire
GeneDx Holdings Corp. (NASDAQ:WGS) Looks Just Right With A 26% Price Jump - Simply Wall St
TD Cowen Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) Stock - MarketBeat
Genedx CEO Katherine Stueland sells shares worth $1.4 million By Investing.com - Investing.com Australia
GeneDx (NASDAQ:WGS) Hits New 52-Week HighShould You Buy? - MarketBeat
2025 investment picks - substack.com
GeneDx Holdings Corp. (NASDAQ:WGS) CEO Katherine Stueland Sells 18,006 Shares - MarketBeat
Kevin Feeley Sells 1,430 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) Stock - MarketBeat
Genedx CFO Kevin Feeley sells $108,736 in stock By Investing.com - Investing.com Australia
Genedx CFO Kevin Feeley sells $108,736 in stock - Investing.com India
Genedx CEO Katherine Stueland sells shares worth $1.4 million - Investing.com
GeneDx (NASDAQ:WGS) Stock Price Up 7.3%Time to Buy? - MarketBeat
When Will GeneDx Holdings Corp. (NASDAQ:WGS) Turn A Profit? - Simply Wall St
Principal Financial Group Inc. Acquires New Stake in GeneDx Holdings Corp. (NASDAQ:WGS) - MarketBeat
Principal Financial Group Inc. Invests $604,000 in GeneDx Holdings Corp. (NASDAQ:WGS) - Defense World
5 Stocks To Watch Heading Into Friday - MSN
Resources Connection, SPS Commerce And 3 Stocks To Watch Heading Into Friday - Benzinga
GeneDx Holdings Appoints Bryan Dechairo as COO - TipRanks
Genedx Holdings Corp Azioni (WGS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.52%
2.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):